Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Nomampondo Barnabas"'
Autor:
Francois van Loggerenberg, Koleka Mlisana, Carolyn Williamson, Sara C Auld, Lynn Morris, Clive M Gray, Quarraisha Abdool Karim, Anneke Grobler, Nomampondo Barnabas, Itua Iriogbe, Salim S Abdool Karim, CAPRISA 002 Acute Infection Study Team
Publikováno v:
PLoS ONE, Vol 3, Iss 4, p e1954 (2008)
To describe the baseline demographic data, clinical characteristics and HIV-incidence rates of a cohort at high risk for HIV infection in South Africa as well as the challenges experienced in establishing and maintaining the cohort.Between August 200
Externí odkaz:
https://doaj.org/article/7ed39f71b8ab4a56b627ceddb91f31fd
HIV vaccine-induced sero-reactivity: a challenge for trial participants, researchers, and physicians
Autor:
Yegor Voronin, Helene Zinszner, Carissa Karg, Katie Brooks, Robert Coombs, John Hural, Renee Holt, Pat Fast, Mary Allen, Michael Busch, Ulrich Fruth, Hana Golding, Surender Khurana, Joseph Mulenga, Sheila Peel, Marco Schito, Nomampondo Barnabas, Christopher Bentsen, Barney Graham, Glenda Gray, Andrew Levin, Margaret McCluskey, Robert O’Connell, Bill Snow, Mark Ware
Publikováno v:
Vaccine. 33(10)
Antibody-inducing vaccines are a major focus in the preventive HIV vaccine field. Because the most common tests for HIV infection rely on detecting antibodies to HIV, they may also detect antibodies induced by a candidate HIV vaccine. The detection o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b925c546ee3f9bb75069f40a7ff8f3b7
https://pubmed.ncbi.nlm.nih.gov/25649349
https://pubmed.ncbi.nlm.nih.gov/25649349
Autor:
Dorothy Namutamba, Taharqa Elnour, Mike Frick, Laia Ruiz Mingote, Natalie Skipper, Carmen Contreras, Cynthia Lee, Francis Apina, Debra Shelly, Nomampondo Barnabas, Ezio Tavora dos Santos Filho, Barbara Seaworth
Publikováno v:
Lancet (London, England). 385(9966)
WHO has issued normative guidance on bedaquiline, 2 which is available on the market in the USA and through compassionate use in other countries. As the fi rst new drug from a novel class approved to treat tuberculosis in more than 40 years, bedaquil
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::184213e1f3a1919a852d87cc34f09ab5
https://pubmed.ncbi.nlm.nih.gov/25943935
https://pubmed.ncbi.nlm.nih.gov/25943935
Autor:
Clive M. Gray, Lynn Morris, Francois van Loggerenberg, Salim S. Abdool Karim, Anneke Grobler, Quarraisha Abdool Karim, Itua Iriogbe, Carolyn Williamson, Sara C. Auld, Nomampondo Barnabas, Koleka Mlisana
Publikováno v:
PLoS One
PLoS ONE
PLoS ONE, Vol 3, Iss 4, p e1954 (2008)
PLoS ONE
PLoS ONE, Vol 3, Iss 4, p e1954 (2008)
Objectives To describe the baseline demographic data, clinical characteristics and HIV-incidence rates of a cohort at high risk for HIV infection in South Africa as well as the challenges experienced in establishing and maintaining the cohort. Method
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4d936dc623eac6a6520aa4f9e2f08143
